The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2016

Filed:

Dec. 26, 2012
Applicant:

Shilpa Medicare Limited, Raichur, IN;

Inventors:

Vimal Kumar Shrawat, Raichur, IN;

Prashant Purohit, Raichur, IN;

Rafiuddin Dr, Raichur, IN;

Vinod Kumar Singh, Raichur, IN;

Akshay Kant Chaturvedi, Raichur, IN;

Assignee:

SHILPA MEDICARE LIMITED, Karnataka, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 305/14 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 305/14 (2013.01); C07D 413/12 (2013.01);
Abstract

The present invention provides a non-solvated amorphous form of (2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3[ (tert-butoxy carbonyl) amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate or Cabazitaxel (I), and process for preparation thereof. The present application also provides a non-solvated amorphous form of (2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3[ (tert-butoxy carbonyl) amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate or Cabazitaxel (I) having an XRPD pattern as per FIG., and IR spectrum as per FIG.and is useful as an active pharmaceutical in a pharmaceutical composition comprising thereof and has anti-cancer activity.


Find Patent Forward Citations

Loading…